Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) EPS (Weighted Average and Diluted) (2021 - 2025)

Biofrontera (BFRI) has 5 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.62 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 34.04% year-over-year to -$0.62; the TTM value through Sep 2025 reached -$1.5, down 320.59%, while the annual FY2024 figure was -$3.22, 75.27% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.62 in Q3 2025 per BFRI's latest filing, down from -$0.58 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $4.55 in Q4 2023 and bottomed at -$7.23 in Q2 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.92, with a median of -$0.52 recorded in 2025.
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 262.5% in 2023, then plummeted 1060.0% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$2.0 in 2021, then crashed by 40.0% to -$2.8 in 2022, then soared by 262.5% to $4.55 in 2023, then crashed by 96.26% to $0.17 in 2024, then crashed by 464.71% to -$0.62 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.62 in Q3 2025, -$0.58 in Q2 2025, and -$0.47 in Q1 2025.